Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gal Markel

Showing results (11-20 of 137) with videos related to

Pageof 14
Sort By:
The Israel Medical Association Journal : IMAJ|June 14, 2008
Hydrazine--the space era agentIgor Makarovsky, Gal Markel, Tsvika Dushnitsky, et al.
The Israel Medical Association Journal : IMAJ|July 9, 2008
Hydrogen fluoride--the protoplasmic poisonIgor Makarovsky, Gal Markel, Tsvika Dushnitsky, et al.
The Israel Medical Association Journal : IMAJ|August 30, 2008
Ammonia--when something smells wrongIgor Makarovsky, Gal Markel, Tsvika Dushnitsky, et al.
Clinical Cardiology|February 14, 2013
Prevention of recurrent pericarditis with colchicine in 2012Gal Markel, Massimo Imazio, Antonio Brucato, et al.
Bioinformatics (Oxford, England)|March 15, 2020
κ-helix and the helical lock and key model: a pivotal way of looking at polyproline IITomer Meirson, David Bomze, Gal Markel, et al.
American Journal of Cancer Research|September 9, 2020
ADAR1 regulates melanoma cell invasiveness by controlling beta3-integrin via microRNA-30 family membersYael Nemlich, Michal J Besser, Jacob Schachter, et al.
Oncotarget|February 18, 2016
SOX9 indirectly regulates CEACAM1 expression and immune resistance in melanoma cellsShira Ashkenazi, Rona Ortenberg, Michal Besser, et al.
Oncotarget|July 10, 2015
miR-17 regulates melanoma cell motility by inhibiting the translation of ETV1Ronit Cohen, Eyal Greenberg, Yael Nemlich, et al.
Plos One|September 6, 2007
CD100 on NK cells enhance IFNgamma secretion and killing of target cells expressing CD72Sa'ar Mizrahi, Gal Markel, Angel Porgador, et al.
British Journal of Cancer|May 6, 2024
Assessing the effect of metastasis-directed therapy in oligometastatic disease using the restricted mean survival timeItamar Averbuch, Assaf Moore, Ethan B Ludmir, et al.
Pageof 14

Showing results (11-20 of 137) with videos related to

Sort By:
Pageof 14
The Israel Medical Association Journal : IMAJ|June 14, 2008
Hydrazine--the space era agentIgor Makarovsky, Gal Markel, Tsvika Dushnitsky, et al.
The Israel Medical Association Journal : IMAJ|July 9, 2008
Hydrogen fluoride--the protoplasmic poisonIgor Makarovsky, Gal Markel, Tsvika Dushnitsky, et al.
The Israel Medical Association Journal : IMAJ|August 30, 2008
Ammonia--when something smells wrongIgor Makarovsky, Gal Markel, Tsvika Dushnitsky, et al.
Clinical Cardiology|February 14, 2013
Prevention of recurrent pericarditis with colchicine in 2012Gal Markel, Massimo Imazio, Antonio Brucato, et al.
Bioinformatics (Oxford, England)|March 15, 2020
κ-helix and the helical lock and key model: a pivotal way of looking at polyproline IITomer Meirson, David Bomze, Gal Markel, et al.
American Journal of Cancer Research|September 9, 2020
ADAR1 regulates melanoma cell invasiveness by controlling beta3-integrin via microRNA-30 family membersYael Nemlich, Michal J Besser, Jacob Schachter, et al.
Oncotarget|February 18, 2016
SOX9 indirectly regulates CEACAM1 expression and immune resistance in melanoma cellsShira Ashkenazi, Rona Ortenberg, Michal Besser, et al.
Oncotarget|July 10, 2015
miR-17 regulates melanoma cell motility by inhibiting the translation of ETV1Ronit Cohen, Eyal Greenberg, Yael Nemlich, et al.
Plos One|September 6, 2007
CD100 on NK cells enhance IFNgamma secretion and killing of target cells expressing CD72Sa'ar Mizrahi, Gal Markel, Angel Porgador, et al.
British Journal of Cancer|May 6, 2024
Assessing the effect of metastasis-directed therapy in oligometastatic disease using the restricted mean survival timeItamar Averbuch, Assaf Moore, Ethan B Ludmir, et al.
Pageof 14